Identification | Back Directory | [Name]
Sitofibrate | [CAS]
55902-94-8 | [Synonyms]
Sitofibrate Stigmast-5-en-3-ol, 3-[2-(4-chlorophenoxy)-2-methylpropanoate], (3β)- | [Molecular Formula]
C39H59ClO3 | [MDL Number]
MFCD00865756 | [MOL File]
55902-94-8.mol | [Molecular Weight]
611.34 |
Hazard Information | Back Directory | [Uses]
Sitofibrate is a Clofibrate (HY-B0287) derivative. Sitofibrate is aperoxisome proliferator activated receptor-α (PPAR-α) agonist. Sitofibrate is an antihyperlipidemic agent[1]. | [IC 50]
PPAR-α | [References]
[1] Morton, I.K.M., et al. salbutamol hemisulfate. (1999). S. In: Concise Dictionary of Pharmacological Agents. Springer, Dordrecht. |
|
Company Name: |
Biorbyt Ltd.
|
Tel: |
+44 (0)1223 859 353 |
Website: |
http://www.biorbyt.com |
Company Name: |
Pharma Affiliates
|
Tel: |
172-5066494 |
Website: |
www.yuhua99.com/ShowSupplierProductsList694812/0_EN.htm |
Company Name: |
Leancare Ltd.
|
Tel: |
+33 962096793 |
Website: |
www.leancare.co.uk |
|